Anixa Biosciences Inc — Director's Dealing 2012

Sep 25, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2012-09-21

Reporting Person: Williams Kent B. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-09-19	Employee Stock Options (Right to Buy)	$0.2225	A	750000	Acquired	2022-09-19	Common Stock (750000)	Direct

Footnotes

F1: On September 19, 2012, the reporting person was granted an option to purchase 750,000 shares of common stock. Options for 250,000 are immediately vested and the balance vests in two equal annual installments commencing on September 19, 2013.